Search

Your search keyword '"Mizusawa Y"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Mizusawa Y" Remove constraint Author: "Mizusawa Y" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
164 results on '"Mizusawa Y"'

Search Results

3. Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome

4. SCN5A mutation type and a genetic risk score associate variably with brugada syndrome phenotype in SCN5A families

5. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

6. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

8. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome .

11. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)

14. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death

15. Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study

16. The effect of blue-blocking intraocular lenses on circadian biological rhythm: protocol for a randomised controlled trial (CLOCK-IOL colour study)

17. Characterization of SEMA3A-encoded semaphorin as a naturally cccurring Kv4.3 protein inhibitor and its contribution to Brugada Syndrome

18. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

19. Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter- defibrillator therapy

20. Genome-Wide Association Analysis Identifies 3 Common Variants Predisposing to Brugada Syndrome, a Rare Disease with High Risk of Sudden Cardiac Death

23. Session 61: Effects of interventions on embryo quality

25. QUALITY AND SAFETY OF ART THERAPIES

26. EARLY PREGNANCY

28. POSTER VIEWING SESSION - EMBRYOLOGY

31. P.2.14 Clinical and electrophysiological characteristics of cardiac arrest survivors without structural heart disease

37. Influence of meals on variations of ST segment elevation in patients with Brugada syndrome.

40. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest.

43. New Class of Corticotropin-Releasing Factor (CRF) Antagonists:  Small Peptides Having High Binding Affinity for CRF Receptor

48. P336 Exome sequencing of multiple affected individuals from an Irish family with Brugada Syndrome uncovers a novel locus for the disorder.

Catalog

Books, media, physical & digital resources